Latest NVIV reports update at 2023-11-08: 2023-Q3 ∙ 2022-Q4 ∙ 2022-Q3
  1. Home
  2. Stock quotes
  3. InVivo Therapeutics Holdings Corp.
  4. Financial Ratios
InVivo Therapeutics Holdings Corp. logo
InVivo Therapeutics Holdings Corp. NVIV
$ 0.31 -37.48%
mail-toReport an Error

InVivo Therapeutics Holdings Corp. Financial Ratios 2011-2024 | NVIV

Annual Financial Ratios InVivo Therapeutics Holdings Corp.

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -0.3 -1.3 -0.6 -0.2 -0.4 -0.7 -6.2 -3.5 -9.4 -4.4 28.3 -3.1

P/S

 - - - - - - - - - - - -

EPS

 -6.8 -7.5 -1.3 -35.3 -140.8 -20.3 -0.8 -1.3 -0.2 -0.5 0.1 -0.7

EV (Enterprise Value)

 -10.1 M -2.47 M -11.1 M -445 K -6.01 M 9.15 M 130 M 107 M 170 M 160 M 138 M 139 M

EBITDA per Share

 -6.89 -7.45 -1.8 -33.3 -76.2 -551 -568 -615 -580 -741 -589 -492

EV/EBITDA

 -28.6 1.5 0.4 0.6 -0.3 -5.3 -4.5 -9.5 -8.7 -9.7 -12.1

PEG

 -0.02 -0.09 -0.01 -0.0 -0.0 0.1 -0.16 0.07 -0.16 0.01 0.26 0.02

P/B

 0.2 0.7 0.3 0.4 0.5 1.8 5.0 6.9 29.3 13.2 -57.2 -3.4

P/CF

 -0.3 -1.5 -0.6 -0.2 -0.7 -0.9 -8.7 -7.2 -11.3 -10.9 -10.7 -13.9

ROE %

 -66.62 -54.62 -47.29 -211.89 -145.39 -264.54 -80.96 -196.79 -310.00 -300.67 -201.86 111.45

ROA %

 -55.73 -45.45 -41.41 -126.86 -127.46 -190.42 -67.38 -152.87 -109.90 -226.69 29.04 -609.03

ROCE %

 -67.64 -54.65 -45.63 -172.58 -78.95 -224.94 -80.38 -121.20 -237.28 -128.17 1751.61 27.90

Current Ratio

 6.1 6.0 10.0 2.5 7.8 4.4 7.0 6.3 1.6 6.4 0.8 0.1

DSO

 - - - - - - - - - - - -

DIO

 - - - - - - - - - - - -

DPO

 - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios InVivo Therapeutics Holdings Corp.

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -0.87 -0.62 -0.85 - -1.98 -1.97 -1.94 - -1.79 -1.68 -1.89 - -0.47 -0.49 -2.47 - -8.63 -10.13 -8.49 - -0.42 -7.48 -3.34 - -6.99 -4.92 -4.98 - -0.19 -0.16 -0.24 - -0.09 -0.39 -0.64 - -0.01 -0.17 -0.28 - -0.07 -0.2 -0.2 - 0.12 0.03 0.05 - 0.06 -0.03 -0.02

EBITDA per Share

 -0.91 -0.67 -0.9 - -2 -1.96 -1.94 - -1.76 -1.67 -1.87 - -0.46 -0.49 -2.48 - -8.66 -10.4 -8.9 - -0.27 -1.59 -3.34 - -4.43 -5.17 -5.09 - -0.17 -0.17 -0.19 - -0.2 -0.2 -0.21 - -0.15 -0.2 -0.26 - -0.06 -0.07 -0.04 - -0.04 -0.04 -0.04 - -0.04 -0.05 -0.03

ROE %

 -91.57 -88.61 -93.10 -65.62 -77.32 -61.74 -50.42 -30.32 -42.20 -42.37 -43.88 -35.87 -83.85 -119.96 -164.87 -151.50 -171.20 -142.92 -166.92 -129.71 -222.20 -294.97 -277.37 -218.41 -239.81 -168.73 -123.93 -62.19 -75.82 -68.05 -111.83 -168.83 -189.33 -196.19 -196.11 -168.33 -210.51 -232.20 -281.42 -256.39 -603.91 -909.24 -893.67 -579.11 -588.95 -251.28 -151.62 -1.34 -9.84 4.40 4.10

ROA %

 -78.20 -70.68 -73.08 -51.87 -62.26 -52.03 -44.06 -27.37 -37.77 -37.78 -38.82 -31.41 -60.14 -78.47 -102.19 -90.70 -107.98 -96.53 -133.22 -113.72 -180.29 -229.58 -204.32 -157.22 -175.03 -126.27 -96.03 -51.76 -62.35 -55.13 -88.14 -131.15 -138.42 -135.10 -109.02 -59.68 -91.48 -116.02 -177.74 -193.31 -143.33 -61.54 35.73 83.30 137.09 140.89 103.16 7.35 53.79 -24.03 -22.41

ROCE %

 -95.92 -91.94 -95.23 -66.21 -77.93 -61.91 -50.51 -30.34 -42.23 -42.42 -43.95 -35.99 -84.93 -121.96 -168.70 -156.87 -169.98 -134.17 -93.44 -60.56 -123.03 -172.39 -223.44 -196.94 -217.25 -175.08 -126.56 -59.52 -94.19 -108.55 -122.59 -101.25 -171.96 -208.01 -254.06 -236.48 -278.43 -249.66 -208.93 -103.41 19.55 184.46 343.05 348.72 355.82 239.96 128.83 19.71 7.10 8.11 4.50

Current Ratio

 14.4 7.6 7.2 6.1 4.1 4.9 6.1 6.0 9.0 10.3 12.8 8.0 8.0 8.0 8.0 2.5 2.5 2.5 2.5 8.1 8.1 8.1 8.1 3.6 3.6 3.6 3.6 6.0 6.0 6.0 6.0 4.5 4.5 4.5 4.5 1.6 1.6 1.6 1.6 4.1 4.1 4.1 4.1 0.9 0.9 0.9 0.9 0.1 0.1 0.1 0.1

DSO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency